Search

Rodolfo J Gonzalez

from San Diego, CA
Age ~46
Get Report
Also known as:
Rudolfo Gonzalez
Related to:
Lucila G Mathena, 66Chalena Tomz, 50Brenda Gonzalez, 47William J Quidachay, 74Juan Rodriquez, 42Gabriel M Gonzales, 44Phillip Quidachay, 53Mi-Cha GonzalesPollyanna Quidachay, 50Mariaguadalupe GonzalezPeter J Quidachay, 48
Connected to:
Abelina Gonzalezsaucedo, 73Abull A Gonzalez, 52Aceda J Gonzalez, 28Adalberto C Gonzalez, 56Adanna Gonzales, 34Adela V Gonzalezvazquez, 52Adella Gonzalez, 54Adelma Gonzalez, 54Adileni Y Gonzalez, 28Adora E Gonzalez, 58

Rodolfo Gonzalez Phones & Addresses

  • San Diego, CA
  • Chula Vista, CA
  • National City, CA
  • El Cajon, CA

Professional Records

Medicine Doctors

Rodolfo Gonzalez Photo 1

Rodolfo H. Gonzalez

View page
Specialties:
Obstetrics & Gynecology
Work:
Rodolfo H Gonzalez MD
1860 Town Ctr Dr STE 350, Reston, VA 20190
(703) 435-8256 (phone), (703) 435-3337 (fax)

Rodolfo H Gonzalez MD
8301 Arlington Blvd STE 409, Fairfax, VA 22031
(703) 208-7355 (phone), (703) 208-7358 (fax)
Education:
Medical School
Univ Peruana Cayetano Heredia, Prog Acad De Med, Lima, Peru
Graduated: 1989
Procedures:
Amniocentesis
Myomectomy
Ovarian Surgery
Tubal Surgery
Vaginal Repair
Bladder Repair
Cesarean Section (C-Section)
Cystoscopy
Delivery After Previous Caesarean Section
Hemorrhoid Procedures
Hysterectomy
Oophorectomy
Skin Tags Removal
Vaginal Delivery
Conditions:
Abnormal Vaginal Bleeding
Diabetes Mellitus Complicating Pregnancy or Birth
Endometriosis
Polycystic Ovarian Syndrome (PCOS)
Pregnancy-Induced Hypertension
Languages:
English
Spanish
Description:
Dr. Gonzalez graduated from the Univ Peruana Cayetano Heredia, Prog Acad De Med, Lima, Peru in 1989. He works in Reston, VA and 1 other location and specializes in Obstetrics & Gynecology. Dr. Gonzalez is affiliated with Inova Fairfax Medical Campus and Reston Hospital Center.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Rodolfo Gonzalez
President
Rotary National Award for Space Achievement Foundation, Inc
Rodolfo Gonzalez
Director
A Texas Heart for Families, Inc
Rodolfo Gonzalez
Managing
San Diego Portable Rentals LLC
Rental Company for Portable Devices · Equipment Rental/Leasing
482 W San Ysidro Blvd, San Diego, CA 92173
Rodolfo Gonzalez
Partner
Industrial Baker Gonzalez
Whol Groceries
2036 Dairy Mart Rd, San Diego, CA 92173
Rodolfo Gonzalez
Director, President, Treasurer
Quantz Inc
610 W Ash St, San Diego, CA 92101

Publications

Us Patents

Znf206: Regulator Of Embryonic Stem Cell Self-Renewal And Pluripotency

View page
US Patent:
8071378, Dec 6, 2011
Filed:
Aug 6, 2008
Appl. No.:
12/221824
Inventors:
Evan Yale Snyder - La Jolla CA, US
Rodolfo Gonzalez - La Jolla CA, US
Assignee:
Sanford-Burnham Medical Research Institute - La Jolla CA
International Classification:
C12N 5/00
C12N 5/02
C12N 15/00
US Classification:
435377, 435455, 435325
Abstract:
We have identified ZNF206, a novel repressor of human embryonic stem cell (hESC) differentiation. Repressing extra-embryonic endoderm development preserves the pluripotent state of human embryonic stem cells, and, conversely downregulating expression of ZNF206 in hESCs causes them to upregulate the expression of genes associated with the extra-embryonic endodermal lineage, down-regulate genes associated with the pluripotent state, and may lead to the further emergence of genes associated with even more differentiated lineages and phenotypes.

Mammalian Extraembryonic Endoderm Cells And Methods Of Isolation

View page
US Patent:
20080182328, Jul 31, 2008
Filed:
Dec 19, 2007
Appl. No.:
12/004299
Inventors:
Evan Y. Snyder - La Jolla CA, US
Rodolfo Gonzalez - La Jolla CA, US
Jeanne F. Loring - La Jolla CA, US
Prithi Rajan - La Jolla CA, US
Assignee:
The Burnham Institute - La Jolla CA
International Classification:
C12N 5/00
C12N 5/02
US Classification:
435353, 435363, 435404, 4353723, 435395, 435354
Abstract:
An isolated mammalian extraembryonic endoderm-like cell line is provided. Methods for producing isolated mammalian extraembryonic endoderm-like cell line derived from a mammalian pluripotent stem cell culture are provided. Primate or human embryonic stem cells (ESCs) spontaneously generate the primate or human extraembryonic endoderm-like cell line wherein the extraembryonic endoderm-like cells sustain the pluripotence of the primate or human ESCs.

Znf206: A Novel Regulator Of Embryonic Stem Cell Self-Renewal And Pluripotency

View page
US Patent:
20120196922, Aug 2, 2012
Filed:
Dec 5, 2011
Appl. No.:
13/311511
Inventors:
Evan Yale SNYDER - La Jolla CA, US
Rodolfo GONZALEZ - La Jolla CA, US
Assignee:
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE - La Jolla CA
International Classification:
A61K 31/713
C07K 14/47
C07K 16/18
C40B 30/04
G01N 33/566
C12N 15/85
A61P 35/00
C07H 21/04
C12Q 1/68
US Classification:
514 44 R, 536 235, 530350, 5303898, 5303873, 5303882, 435 611, 436501, 435455, 506 9, 435 71
Abstract:
We have identified ZNF206, a novel repressor of human embryonic stem cell (hESC) differentiation. Repressing extra-embryonic endoderm development preserves the pluripotent state of human embryonic stem cells, and, conversely down-regulating expression of ZNF206 in hESCs causes them to upregulate the expression of genes associated with the extra-embryonic endodermal lineage, down-regulate genes associated with the pluripotent state, and may lead to the further emergence of genes associated with even more differentiated lineages and phenotypes.

Chemical Differentiation Of Pluripotent Stem Cells Into Retinal Epithelial Cells

View page
US Patent:
20200024573, Jan 23, 2020
Filed:
Sep 16, 2019
Appl. No.:
16/571875
Inventors:
- Carlsbad CA, US
Rodolfo Gonzalez - Carlsbad CA, US
International Classification:
C12N 5/079
A61K 35/30
A61K 35/545
Abstract:
The present invention is based in part on a chemically defined method of generating retinal epithelial cells and retinal pigmented epithelial cells from human pluripotent stem cells (hpSCs). The present invention also provides methods and kits for treating degenerative eye disorders.

Use Of Neural Cells Derived From Human Pluripotent Stem Cells For The Treatment Of Neurodegenerative Diseases

View page
US Patent:
20180339000, Nov 29, 2018
Filed:
Aug 6, 2018
Appl. No.:
16/056478
Inventors:
- Carlsbad CA, US
Rodolfo Gonzalez - Carlsbad CA, US
Ibon Garitaonandia - Carlsbad CA, US
International Classification:
A61K 35/545
C12N 5/074
A61K 35/30
C12N 5/0797
Abstract:
The present invention is based in part methods for treating neurodegenerative diseases and disorders. Specifically, the present invention disclose methods for treating neurodegenerative disorders suing neural stem cells (NSCs) and/or pluripotent stem cell (PSC) derived neurons or neuron precursor cells. The present invention also discloses methods to induce endogenous dopaminergic neurons to release dopamine and increase the levels of dopamine in a subject.

Use Of Neural Cells Derived From Human Pluripotent Stem Cells For The Treatment Of Neurodegenerative Diseases

View page
US Patent:
20180339001, Nov 29, 2018
Filed:
Aug 6, 2018
Appl. No.:
16/056480
Inventors:
- Carlsbad CA, US
Rodolfo Gonzalez - Carlsbad CA, US
Ibon Garitaonandia - Carlsbad CA, US
International Classification:
A61K 35/545
C12N 5/074
A61K 35/30
C12N 5/0797
Abstract:
The present invention is based in part methods for treating neurodegenerative diseases and disorders. Specifically, the present invention disclose methods for treating neurodegenerative disorders suing neural stem cells (NSCs) and/or pluripotent stem cell (PSC) derived neurons or neuron precursor cells. The present invention also discloses methods to induce endogenous dopaminergic neurons to release dopamine and increase the levels of dopamine in a subject.

Derivation Of Neural Crest Stem Cells And Uses Thereof

View page
US Patent:
20170260501, Sep 14, 2017
Filed:
Nov 24, 2015
Appl. No.:
15/529490
Inventors:
- Carlsbad CA, US
Rodolfo Gonzalez - Carlsbad CA, US
International Classification:
C12N 5/0735
G01N 33/50
C12N 5/07
C12N 5/0775
Abstract:
The present invention is based in part the discovery of methods for the generation of neural crest stem cells (NCSCs) from human pluripotent stem cells (hPSCs). Specifically, the present invention discloses methods for the use of a combination of rho-associated protein kinase (ROCK) inhibitors, glycogen synthase kinase 3 (GSK-3) inhibitors, activing receptor like kinase (ALK) receptor inhibitors and bone morphogenic protein (BMP) receptor inhibitors to derive NCSCs from hPSCs. The present invention also discloses methods to treat neurocristopathic diseases and disorders using NCSCs derived from hPSCs.

Chemical Differentiation Of Pluripotentstem Cells Into Retinal Epithelial Cells

View page
US Patent:
20160122711, May 5, 2016
Filed:
May 14, 2015
Appl. No.:
14/712633
Inventors:
- Carlsbad CA, US
Rodolfo Gonzalez - Carlsbad CA, US
International Classification:
C12N 5/079
A61K 35/30
Abstract:
The present invention is based in part on a chemically defined method of generating retinal epithelial cells and retinal pigmented epithelial cells from human pluripotent stem cells (hpSCs). The present invention also provides methods and kits for treating degenerative eye disorders.
Control profile
Rodolfo J Gonzalez from San Diego, CA, age ~46 Get Report